Our previous work demonstrated that increased cholinergic pathway activation through a chronic administration of paraoxon, an irreversible specific inhibitor of AChE, protected against development of T1D in MLD-STZ mouse model (36). The gene discussed is ACHE; the disease is type 1 diabetes mellitus.